Interventional Oncology Market by Procedure (Tumor ablation [Radiofrequency, Microwave], Radiotherapy [External, Internal, Systemic], Embolization, Proton Therapy), Application (Lung, Breast, Liver), and End user - Global Forecast to 2025

  • Report ID:MRHC - 104250
  • Pages: 190
  • Feb 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency & Limitation
           1.2.1. Currency
           1.2.2. Limitation
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research
           2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Growing Preference for Minimally Invasive Treatment Procedures
                     4.2.1.2. Increasing Prevalence of Cancer
                     4.2.1.3. Rising Number of Hospitals
                     4.2.1.4. Technological Advancements in the Field of Radiology
           4.2.2. Restraints
                     4.2.2.1. High cost and Risks Associated with the Interventional Oncology Procedures
                     4.2.2.2. Paucity of Skilled Healthcare Professionals
           4.2.3. Opportunities
                     4.2.3.1. Significant Opportunities from Developing Economies
                     4.2.3.2. Introduction of Cloud-based Medical Imaging
           4.2.4. Trend
                     4.2.4.1. Growing Integration of Image-guided Solutions with Interventional Oncology Procedures
           4.2.5. Market Share Analysis

5. Interventional Oncology market, By Procedure
    5.1. Introduction
    5.2. Tumor Ablation 
           5.2.1. Radiofrequency (RF) Ablation
           5.2.2. Microwave Ablation
           5.2.3. Cryoablation 
           5.2.4. Other Ablation Technologies (Image guided ablation includes irreversible electroporation, laser, HIFU)
    5.3. Radiotherapy
           5.3.1. External Beam Radiotherapy
           5.3.2. Internal Beam Radiotherapy
           5.3.3. Systemic Radiotherapy
    5.4. Embolization
           5.4.1. Chemoembolization
           5.4.2. Radioembolization
    5.5. Proton Therapy

6. Interventional Oncology market, By Application
    6.1. Introduction
    6.2. Lung Cancer
    6.3. Breast Cancer
    6.4. Liver Cancer
    6.5. Kidney Cancer
    6.6. Bone metastasis
    6.7. Prostate Cancer
    6.8. Other Cancers

7. Interventional Oncology market, By End User
    7.1. Introduction
    7.2. Hospitals
    7.3. Ambulatory care centers
    7.4. Research and academia

8. Interventional Oncology Market, by Geography
    8.1. Introduction
    8.2. North America
           8.2.1. U.S.
           8.2.2. Canada
    8.3. Europe
           8.3.1. Germany
           8.3.2. France
           8.3.3. U.K.
           8.3.4. Italy
           8.3.5. Spain
           8.3.6. Rest of Europe
    8.4. Asia-Pacific
           8.4.1. Japan
           8.4.2. China
           8.4.3. India
           8.4.4. Rest of Asia-Pacific
    8.5. Rest of the World
           8.5.1. Latin America
           8.5.2. Middle East & Africa

9. Global Interventional Oncology Market - Competitive Landscape
    9.1. Introduction
    9.2. Competitive Benchmarking

10. Company Profiles
      10.1. Boston Scientific Corporation
      10.2. Varian Medical Systems, Inc.
      10.3. Elekta AB
      10.4. Merit Medical Systems, Inc.
      10.5. Profound Medical Corp.
      10.6. AtriCure, Inc.
      10.7. AngioDynamics, Inc.
      10.8. BTG plc
      10.9. Terumo Corporation
      10.10. Siemens AG
      10.11. Koninklijke Philips N.V.
      10.12. GE Healthcare
      10.13. Cook medical
      10.14. Medtronic, PLC.
      10.15. Healthtronics, Inc
      10.16. Edap Tms S.A.. 
      10.17. Neuwave Medical, Inc.
      10.18. Accuray Incorporated
      10.19. Ion Beam Applications, SA
      10.20. Nordion Inc.
      10.21. C. R. Bard, Inc.
      10.22. Isoray Medical, Inc.
      10.23. RaySearch Laboratories AB

11. Appendix

Interventional oncology is considered as the most promising and rapidly growing offshoot of interventional radiology. It involves technique guided imaging systems to directly target solid tumors. It provided clinicians the ability to perform targeted procedures that can be characterized as either arterial or ablative. Also, it enables the healthcare providers to conduct minimally invasive surgeries, which is ideal for patients whose cancers are inoperable or cannot undergo chemotherapy. Growing preference for minimally invasive treatment procedures, increasing incidence & prevalence of cancer, rising number of hospitals, and technological advancements in the field of radiology are steadily driving the growth of interventional oncology market.

According to International Agency for Research on Cancer (IARC), WHO, in 2018, 18.1 million new cancer cases were reported, globally. Also, as compared to other world regions, the proportions of cancer cases in Asia are higher. The death rate of the disease in the region is also comparatively higher and holds 57.3% of the global deaths from cancer.

Analysis of market segments

The global interventional oncology market is segmented by procedure (tumor ablation, radiotherapy, embolization, proton therapy), application (lung, breast, liver, kidney, bone metastasis, prostrate, and others), and end user (hospital, ambulatory care centers, research and academia).

On the basis of procedure, tumor ablation is identified as the most preferred procedure by clinicians for tumor, owing to its better penetration in tumors and precise treatment capabilities in non-surgical candidates.

On the basis of application, lung cancer commanded the largest share of the global interventional oncology market in 2018. The high share of this segment is attributed to large volume of new lung cancer cases.

Key players in the interventional oncology market

As technological advances are made, the key players are consistently translating such advancements into innovative products enhancing the ability of the procedures and allowing treatment with greater ease. In addition, the key players have adopted various strategies like product launches, acquisitions, and collaborations to meet the demand of interventional oncology space. In January 2018, Varian Medical Systems, Inc., entered into agreement to acquire all the outstanding shares of Sirtex Medical Limited. This acquisition was expected to extend Varian Medical Systems’ leadership in radiation medicine industry and will expand market share into interventional oncology. Also, in March 2018, GE Healthcare launched advanced radiology ultrasound system LOGIQ E10 with high processing power and improved imaging that will significantly improve interventional radiology along with oncological procedures.

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 5 years (2014-2018). The key players profiled in the global interventional oncology market are Boston Scientific Corporation, Varian Medical Systems, Inc., Elekta AB, Merit Medical Systems, Inc., Profound Medical Corp., AtriCure, Inc., AngioDynamics, Inc., BTG plc, Terumo Corporation, Siemens AG, Koninklijke Philips N.V., GE Healthcare, Cook medical, Medtronic, PLC., Healthtronics, Inc., EdapTms S.A., Neuwave Medical, Inc., Accuray Incorporated, Ion Beam Applications, SA, Nordion Inc., C. R. Bard, Inc., Isoray Medical, Inc., and RaySearch Laboratories AB among others.

Future Outlook

Interventional oncology (IO) techniques have proved to be a value aided method in adults. However, the adoption of interventional oncology in pediatrics is limited and challenging and most of the products are not approved for pediatric patients. In future, development of appropriate devices and agents suitable for children are expected to convince pediatric oncologists to incorporate IO therapies into trials and treatments. Moreover, with the integration of imaging techniques, the interventional oncology procedures are expected to enable the clinicians to deliver specific tumoricidal drugs at specific locations with the help of high-resolution and real-time images.

Market Segmentation:

Interventional Oncology Market, by Procedure                                              

  • Tumor Ablation 
    • Radiofrequency (RF) Ablation
    • Microwave Ablation
    • Cryoablation 
    • Other Ablation Technologies
  • Radiotherapy
    • External Beam Radiotherapy
    • Internal Beam Radiotherapy
    • Systemic Radiotherapy
  • Embolization
    • Chemoembolization
    • Radioembolization
  • Proton Therapy

Interventional Oncology market, by Application                                            

  • Lung Cancer
  • Breast Cancer
  • Liver Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Prostate Cancer
  • Other Cancers

Interventional Oncology Market, by End User                                     

  • Hospitals
  • Ambulatory care centers
  • Research and academia

Interventional Oncology Market, by Geography                                             

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa
Report Name
Full Name
Email
Job Title
Company
Country
Phone Number
--
Your Specific Interest
Captcha
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample